Created in 2009 (United States), RILONACEPT REGN own 16 sister brands and 2214 competing brands. The RILONACEPT REGN brand is owned by Regeneron Pharmaceuticals, a company listed in New York. RILONACEPT REGN is part of the Biotechnology activity sector.

RILONACEPT REGN is a brand of Regeneron Pharmaceuticals (REGN) Share price

Share price and profitability of the share Regeneron Pharmaceuticals (RILONACEPT REGN)

Buy Regeneron Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 966.30

Portfolio valuation
Regeneron Pharmaceuticals (RILONACEPT REGN) over 5 years* USD 2,276.96

Stock market history Regeneron Pharmaceuticals (RILONACEPT REGN)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more